Journal profile · Endocrinology & Metabolism
Osteoporosis International
ISSN 0937-941X · eISSN 1433-2965 · Springer London · ENGLAND · Monthly · Founded 1990
Osteoporosis International: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 5.41; hybrid open access; APC about USD 5,090; median 94 days to acceptance (112 articles, last 24 months); community-reported acceptance: about 25%; 302 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Osteoporosis International is published by Springer London and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Bone health and osteoporosis research, Hip and Femur Fractures and Bone health and treatments, together about 54.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
An international multi-disciplinary journal which is a joint initiative between the International Osteoporosis Foundation and the National Osteoporosis Foundation of the USA, Osteoporosis International provides a forum for the communication and exchange of current ideas concerning the diagnosis, prevention, treatment and management of osteoporosis and other metabolic bone diseases. It publishes: original papers - reporting progress and results in all areas of osteoporosis and its related fields; review articles - reflecting the present state of knowledge in special areas of summarizing limited themes in which discussion has led to clearly defined conclusions; educational articles - giving information on the progress of a topic of particular interest; case reports - of uncommon or interesting presentations of the condition. While focusing on clinical research, the Journal will also accept submissions on more basic aspects of research, where they are considered by the editors to be relevant to the human disease spectrum.
From the journal's Aims & Scope
Research area (LetPub): Endocrinology & Metabolism
Editor-in-chief Felicia CosmanPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named United States 40, United Kingdom 12, Canada 10, Belgium 7, Italy 6 (117 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Bone health and osteoporosis researchMedicine34.6%
- Hip and Femur FracturesMedicine10.9%
- Bone health and treatmentsMedicine9.1%
- Bone Metabolism and DiseasesBiochemistry, Genetics and Molecular Biology6%
- Vitamin D Research StudiesMedicine5.1%
- Parathyroid Disorders and TreatmentsMedicine5%
- Bone and Joint DiseasesMedicine4.9%
- Bone fractures and treatmentsMedicine3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.41LetPub ·
- Impact factor (publisher) 2025
- 5.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 5.5Publisher website ·
- CiteScore 2026-06
- 9.8LetPub ·
- SJR 2026-06
- 1.74LetPub ·
- SNIP 2026-06
- 2.07LetPub ·
- h-index
- 157LetPub ·
- h-index
- 242OpenAlex ·
- i10-index
- 6,113OpenAlex ·
- 2-year mean citedness
- 3.8OpenAlex ·
- Self-citation rate
- 7.4%LetPub ·
- Share of gold OA articles
- 38.92%LetPub ·
Volume
- Articles per year
- 228LetPub ·
- Downloads per year (publisher) 2025
- 2,100,000Publisher website ·
Articles by year OpenAlex count · 10,016 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 268 | 104 | 136 |
| 2025 | 302 | 137 | 1,171 |
| 2024 | 223 | 100 | 1,705 |
| 2023 | 220 | 105 | 3,423 |
| 2022 | 253 | 109 | 6,046 |
| 2021 | 312 | 170 | 5,610 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
94 daysMedian, submission to acceptance · P25–P75 46 days – 151 days
- Acceptance to online
- median 22 days (112 articles)
- Submission to online
- median 129 days
- Sample
- 112 articles with submission and acceptance dates (625 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 25%LetPub ·
- Submission to first decision
- 17 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 5,090 / EUR 3,990 / GBP 3,190 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteAuthorship, Open access
- Authorship CME credit request for manuscript review
Manuscript reviewers for Osteoporosis International may claim up to 3 AMA PRA Category 1 Credits™ per review, up to a maximum of five reviews for a total of 15 CME credits per calendar year.
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Osteoporosis International, including information on fees, funding and licences, visit our Open access publishing page.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer London
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1990
- ISSN
- 0937-941X
- Electronic ISSN
- 1433-2965
- Latest issue on the website
- Volume 37, Issue 5 (May 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
FAQ
Frequently asked questions about Osteoporosis International
What CAS zone is Osteoporosis International in?
In the 2025 upgraded edition of the CAS Journal Ranking, Osteoporosis International is in Zone 2 of Medicine, and in Zone 2 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Osteoporosis International?
The latest impact factor listed by LetPub is 5.41; CiteScore 9.8, h-index 242.
How long does peer review take at Osteoporosis International?
Based on the dates recorded on 112 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 94 days (interquartile range 46–151 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 25%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Osteoporosis International based?
Of the 117 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are United States (40), United Kingdom (12) and Canada (10). Counted from the institutions listed on the board page; for reference only.
Which databases index Osteoporosis International?
According to LetPub and DOAJ records, Osteoporosis International is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Osteoporosis International open access, and what is the APC?
Osteoporosis International is a hybrid journal. For open-access publication: APC about USD 5,090.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .